Pandey Salonee, Sahu Mahima, Potdar Varsha, Barde Pradip
1Division of Virology and Zoonoses, ICMR-National Institute for Research in Tribal Health, Nagpur Road, Jabalpur, MP India.
2Influenza Division, ICMR-National Institute of Virology, 20-A Dr. Ambedkar Road Camp, Pune, 411001 India.
Virusdisease. 2018 Sep;29(3):380-384. doi: 10.1007/s13337-018-0474-0. Epub 2018 Jul 16.
Influenza A (H1N1) pdm09 emerged as a major public health problem in 2009. The virus has evolved since then and has acquired several mutations that are epidemiologically important. Viral hemagglutinin (HA) protein is crucial determinant for virus entry, antigenicity, and virulence. The information regarding amino acid substitutions in HA protein of viruses circulating in India during 2017 is lacking. We sequenced HA gene of Influenza A (H1N1) pdm09 detected in Central India and compared the amino acid sequences with present vaccine component and contemporary Influenza A (H1N1) pdm09 sequences. We observed 7 amino acid changes of which two (T508A and I510T) were novel to Central Indian strain. Further, the substitution of Aspartate by Glycine at 222, which is known to have clinical implications, was detected in sequences from western India. The phylogenetic analysis revealed that the circulating virus belonged to clade 6B.1. The appreciable acquired mutations by the virus are not important antigenically and the present vaccine provides effective protection. On the other hand, the amino acid substitutions may play important role in epidemiology; we suggest rigorous molecular monitoring and documentation for timely interventions.
甲型H1N1流感pdm09在2009年成为一个主要的公共卫生问题。从那时起该病毒不断进化,并获得了一些在流行病学上具有重要意义的突变。病毒血凝素(HA)蛋白是病毒进入、抗原性和毒力的关键决定因素。目前缺乏关于2017年在印度传播的病毒HA蛋白中氨基酸替换的信息。我们对在印度中部检测到的甲型H1N1流感pdm09的HA基因进行了测序,并将氨基酸序列与当前疫苗成分以及当代甲型H1N1流感pdm09序列进行了比较。我们观察到7个氨基酸变化,其中两个(T508A和I510T)对印度中部毒株来说是新出现的。此外,在来自印度西部的序列中检测到第222位天冬氨酸被甘氨酸取代,已知这具有临床意义。系统发育分析表明,传播的病毒属于6B.1分支。该病毒获得的明显突变在抗原性方面并不重要,目前的疫苗可提供有效的保护。另一方面,氨基酸替换可能在流行病学中发挥重要作用;我们建议进行严格的分子监测和记录以便及时干预。